Nektar Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Nektar Therapeutics (NKTR) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.040.040.500.731.061.321.34
Short-Term Investments0.210.270.420.710.860.000.00
Cash & Short-Term Investments0.260.300.500.731.061.321.34
Accounts Receivable0.000.000.010.020.040.040.04
Inventory0.000.020.020.020.020.010.01
Other Current Assets0.000.000.020.020.020.050.02
Total Current Assets0.260.330.550.801.141.421.44
Non-Current Assets
Property, Plant & Equipment (Net)0.010.040.090.180.190.130.05
Long-Term Investments0.010.030.000.060.140.000.00
Goodwill0.000.000.080.080.080.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.040.070.160.320.400.490.71
Total Assets0.300.400.711.121.541.982.15
Current Liabilities
Accounts Payable0.010.010.050.030.040.040.06
Short-Term Debt0.020.000.000.000.000.000.00
Accrued Liabilities0.020.020.030.060.080.000.00
Other Current Liabilities0.000.000.010.040.010.040.00
Total Current Liabilities0.060.050.070.090.120.350.08
Non-Current Liabilities
Long-Term Debt0.080.110.110.130.140.140.25
Other Non-Current Liabilities0.100.000.010.000.050.000.09
Total Non-Current Liabilities0.180.100.280.350.390.220.35
Total Liabilities0.240.270.340.440.460.570.43
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-3.60-3.48-3.21-2.84-2.31-1.86-1.42
Accumulated Other Comprehensive Income0.000.00-0.010.000.000.00-0.01
Treasury Stock0.000.000.000.000.000.000.00
Additional Paid-in Capital3.663.613.573.523.393.273.15
Shares Outstanding0.010.010.010.010.000.000.00
Total Stockholders' Equity0.060.130.370.681.081.411.72
Total Liabilities & Equity0.300.400.711.121.541.982.15